A. Negishi

Identification of a predictive biomarker for hematologic toxicities of gemcitabine.

H. Ueno, Tesshi Yamada, S. Hirohashi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative proteomics using formalin‐fixed paraffin‐embedded tissues of oral squamous cell carcinoma

Tesshi Yamada, S. Hirohashi, Y. Kanai, 2009, Cancer science.

Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas.

S. Shioda, H. Ichijo, S. Sasaki, 1989, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics.

N. Sata, S. Hirohashi, T. Itoi, 2009, The Journal of biological chemistry.

Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment*

Yoshiro Saito, Hideki Ueno, Koh Furuta, 2010, Molecular & Cellular Proteomics.

Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray

N. Sata, S. Tsugane, S. Sasazuki, 2011, Cancer science.

Galectin-7 as a potential predictive marker of chemo-and/or radio-therapy resistance in oral squamous cell carcinoma

H. Harada, K. Omura, Y. Nakajima, 2014, Cancer medicine.

[Production of hemidesmosome-specific monoclonal antibody: its application for the diagnosis of oral squamous cell carcinoma].

A. Negishi, 1990, Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan.

Large‐scale quantitative clinical proteomics by label‐free liquid chromatography and mass spectrometry

S. Hirohashi, K. Omura, M. Ono, 2009, Cancer science.